InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,691.01
(
-0.32%
)
Post# of 168
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AnthonyJackson

Send PM Follow Ignore
Followers 0
Posts 13
Boards Moderated 0
Alias Born 12/20/2016

AnthonyJackson

Re: None

Wednesday, 01/18/2017 9:41:39 AM

Wednesday, January 18, 2017 9:41:39 AM

Post# of 168
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading lower by over 5% after the company announced disappointing phase II results for INGREZZA, a highly-selective small molecule Vesicular Monoamine Transporter 2 (VMAT2) inhibitor. Analysts are scrambling to find the proper price target and buy levels. Based on extensive stock chart analysis, the first major support level is at $32.75 The current stock price is $38.00. This will be a buy level for investors looking to pick up Neurocrine Biosciences on the cheap for a swing trade.
Stock market investors buy the Neurocrine Biosciences chart
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NBIX News
More NBIX News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!